Cancer Advisor

GLP-1 receptor agonists such as Semaglutide and Tirzepatide have transformed the treatment of obesity and type 2 diabetes. As their use expands globally, a critical question is emerging: Do GLP-1 drugs reduce cancer risk — or is any apparent benefit simply a consequence of weight loss and improved metabolic health? This article reviews: The established link between obesity and cancer The biological mechanisms affected by GLP-1 therapy Human clinical trial data Observational cancer incidence studies Safety signals (including thyroid cancer) What remains unknown All claims below are supported by peer-reviewed sources. 1. Obesity and Cancer: Established Evidence The link between obesity and cancer is well established. The International Agency for Research on Cancer concluded in 2016 that excess body fat increases the risk of at least 13 cancers (1). Key cancers linked to obesity include: Colorectal Postmenopausal breast Endometrial Pancreatic Liver Mechanisms supported by human and transl...

Can natural supplements influence the outcome of patients with pancreatic cancer? Find out the answers below. What are pancreatic enzymes? Pancreatic enzymes help break down fats, proteins and carbohydrates. A normally functioning pancreas secretes about 8 cups of pancreatic juice into the duodenum, daily. This fluid contains pancreatic enzymes to help with digestion and bicarbonate to neutralize stomach acid as it enters the small intestine. As of February 2023, there are more than 600 studies investigating pancreatic enzyme for pancreatic cancer on  clinicaltrials.gov . Good nutritional care improves outcomes and is critical for your quality of life. The  Pancreatic Cancer Action Network  strongly recommends that patients have access to pancreatic enzymes and see a registered dietitian. Types of Pancreatic Enzymes and Their Effects 1. Lipase Effects: Lipase works with bile from the liver to break down fat molecules so they can be absorbed and used by the body. Shortage ...

The alarming rise of colorectal cancer in younger adults has transformed what was once considered a disease of older age into an urgent public health crisis. In 2026, an estimated 158,850 new cases of colorectal cancer will be diagnosed in the United States, and 55,230 people will die from the disease — including 200 diagnoses each day in people younger than 65. ( American Cancer Society ) The good news is that we have a growing body of evidence—both high-quality scientific studies and patients’ personal experiences—that shows that diet and lifestyle changes can effectively stop cancerous cells in their tracks.  One of the most promising of these studies was performed on mice by a team of ten researchers at the University of Michigan. The study , “Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance,” was published in November in the journal Gastroenterology. For this study, sc...

Is vitamin D the most powerful anti cancer supplement?  Thousands of studies have been done on the health effects of vitamin D, and research shows it is involved in the biology of all the cells and tissues in your body, including your immune cells. Your cells actually need the active form of vitamin D to gain access to the genetic blueprints stored inside. This is one of the reasons why vitamin D has the ability to impact such a wide variety of health problems — from fetal development to cancer. Note: There are more than 12,000 search results on  vitamin D and cancer on PubMed .  2025 Study: Vitamin D Helps Lower Your Risk of Colorectal Cancer A comprehensive analysis published in the journal  Nutrients in April 2025  has discovered a fascinating but substantial link between vitamin D and colorectal cancer (CRC). The researchers reviewed and analyzed data from 50 separate studies involv...